Stock 2276 SHANGHAI CONANT OPTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai Conant Optical Co., Ltd.

Equities

2276

CNE100004Z14

Delayed Hong Kong S.E.
Other stock markets
 22:03:34 2024-05-27 EDT 		5-day change 1st Jan Change
9.91 HKD +0.61% Intraday chart for Shanghai Conant Optical Co., Ltd. +12.09% +40.51%
03-27 Shanghai Conant Optical Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended December 31, 2023, Payable on August 02, 2024 CI
03-27 Shanghai Conant Optical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Its low valuation, with P/E ratio at 9.59 and 8.54 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+40.51% 514M - -
ALCON INC. Stock Alcon Inc.
+25.35% 44.37B
B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
+0.30% 18.86B
B-
AUTEK CHINA INC. Stock Autek China Inc.
-19.49% 2.25B
D+
WARBY PARKER INC. Stock Warby Parker Inc.
+22.34% 2.05B
C+
PEGAVISION CORPORATION Stock Pegavision Corporation
+20.05% 1.15B -
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-37.08% 726M -
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-7.40% 670M -
MENICON CO., LTD. Stock Menicon Co., Ltd.
-42.95% 653M
B-
VIZIONFOCUS INC. Stock Vizionfocus Inc.
+19.39% 482M - -
Investor Rating
-
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
-
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2276 Stock
  4. Ratings Shanghai Conant Optical Co., Ltd.